200 related articles for article (PubMed ID: 16732219)
1. Characteristics of progression of early age-related macular degeneration: the cardiovascular health and age-related maculopathy study.
Tikellis G; Robman LD; Dimitrov P; Nicolas C; McCarty CA; Guymer RH
Eye (Lond); 2007 Feb; 21(2):169-76. PubMed ID: 16732219
[TBL] [Abstract][Full Text] [Related]
2. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Smith W; Wang JJ
Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group.
; Solomon SD; Jefferys JL; Hawkins BS; Bressler NM; Bressler SB
Retina; 2009 Sep; 29(8):1080-90. PubMed ID: 19734762
[TBL] [Abstract][Full Text] [Related]
5. Retinal vessel diameters and the risk of incident age-related macular disease: the Rotterdam Study.
Ikram MK; van Leeuwen R; Vingerling JR; Hofman A; de Jong PT
Ophthalmology; 2005 Apr; 112(4):548-52. PubMed ID: 15808242
[TBL] [Abstract][Full Text] [Related]
6. Five-year incidence of age-related maculopathy: the Visual Impairment Project.
Mukesh BN; Dimitrov PN; Leikin S; Wang JJ; Mitchell P; McCarty CA; Taylor HR
Ophthalmology; 2004 Jun; 111(6):1176-82. PubMed ID: 15177968
[TBL] [Abstract][Full Text] [Related]
7. Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study.
Robman L; McNeil J; Dimitrov P; Dowrick A; Tikellis G; Nicolas C; Cameron J; Guymer R; McGrath B; McCarty C
Ophthalmic Epidemiol; 2004 Jul; 11(3):161-79. PubMed ID: 15370549
[TBL] [Abstract][Full Text] [Related]
8. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.
Wang JJ; Rochtchina E; Lee AJ; Chia EM; Smith W; Cumming RG; Mitchell P
Ophthalmology; 2007 Jan; 114(1):92-8. PubMed ID: 17198852
[TBL] [Abstract][Full Text] [Related]
9. Incidence and progression rates of age-related maculopathy: the Rotterdam Study.
Klaver CC; Assink JJ; van Leeuwen R; Wolfs RC; Vingerling JR; Stijnen T; Hofman A; de Jong PT
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2237-41. PubMed ID: 11527936
[TBL] [Abstract][Full Text] [Related]
10. The course of age-related macular degeneration following bilateral cataract surgery.
Pollack A; Bukelman A; Zalish M; Leiba H; Oliver M
Ophthalmic Surg Lasers; 1998 Apr; 29(4):286-94. PubMed ID: 9571660
[TBL] [Abstract][Full Text] [Related]
11. The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study.
Delcourt C; Lacroux A; Carrière I;
Am J Ophthalmol; 2005 Nov; 140(5):924-6. PubMed ID: 16310477
[TBL] [Abstract][Full Text] [Related]
12. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons.
Wang JJ; Fong CS; Rochtchina E; Cugati S; de Loryn T; Kaushik S; Tan JS; Arnold J; Smith W; Mitchell P
Ophthalmology; 2012 Nov; 119(11):2298-303. PubMed ID: 22959104
[TBL] [Abstract][Full Text] [Related]
13. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
Wong TY; Tikellis G; Sun C; Klein R; Couper DJ; Sharrett AR
Ophthalmology; 2007 Jan; 114(1):86-91. PubMed ID: 17198851
[TBL] [Abstract][Full Text] [Related]
14. Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Rochtchina E; Wang JJ
Am J Ophthalmol; 2007 Apr; 143(4):685-7. PubMed ID: 17386278
[TBL] [Abstract][Full Text] [Related]
15. Australian prospective study of cataract surgery and age-related macular degeneration: rationale and methodology.
Cugati S; de Loryn T; Pham T; Arnold J; Mitchell P; Wang JJ
Ophthalmic Epidemiol; 2007; 14(6):408-14. PubMed ID: 18161615
[TBL] [Abstract][Full Text] [Related]
16. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study.
Buch H; Nielsen NV; Vinding T; Jensen GB; Prause JU; la Cour M
Ophthalmology; 2005 May; 112(5):787-98. PubMed ID: 15878058
[TBL] [Abstract][Full Text] [Related]
17. Retinal vessel signs and 10-year incident age-related maculopathy: the Blue Mountains Eye Study.
Liew G; Kaushik S; Rochtchina E; Tan AG; Mitchell P; Wang JJ
Ophthalmology; 2006 Sep; 113(9):1481-7. PubMed ID: 16828507
[TBL] [Abstract][Full Text] [Related]
18. Drusen classification in bilateral drusen and fellow eye of exudative age-related macular degeneration.
Hamada S; Jain S; Sivagnanavel V; Patel N; Chong NV
Eye (Lond); 2006 Feb; 20(2):199-202. PubMed ID: 15746948
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
[TBL] [Abstract][Full Text] [Related]
20. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.
Jonasson F; Arnarsson A; Peto T; Sasaki H; Sasaki K; Bird AC
Ophthalmology; 2005 Jan; 112(1):132-8. PubMed ID: 15629833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
